The FDA recently released draft guidance on the use of digital health technologies (DHTs) in clinical trials.

​Our clinical science and ePRO expert, Dr. Bill Byrom, provides a summary of the key takeaways as well as analysis in this whitepaper. You'll learn about:

• Device selection, validation, and usability
• Regulatory considerations
• Supplemental recommendations by industry groups such as DiMe, DIA, and C-Path